BRF's $150M Argentine chicken bet never won export access — sold in three parts

In 2011, BRF paid about $150 million to take control of Avex, an Argentine chicken business at Río Cuarto in Córdoba province, along with the pasta-and-sauces maker Danica. The plan was to turn Argentina into a major chicken-export platform. It never happened: the country lacked the export accreditations needed, its grain harvests caused problems, and Avex failed to develop the network of integrated chicken suppliers that underpins BRF's Brazilian operation — an industry executive estimated it would have needed another $50 million of investment to build one.

When the moment to fix Avex came, BRF chose otherwise. Between 2014 and 2015 the company considered making those investments, but preferred to acquire Argentine pork brands and operations (Calchaquí and Campo Austral) to reduce Avex's weight on the balance sheet. The chicken business kept draining the Brazilian parent: Avex was responsible for more than 50% of the losses BRF recorded in the Southern Cone, where 2017 Ebit came in negative at R$81 million — even though Argentina generated about 80% of the region's R$1.8 billion revenue.

Competition closed the trap. In 2016 BRF tried importing breeding hens — fertile eggs from Brazil's south — but Argentine restrictions blocked it, and sources told Valor that Granja Tres Arroyos, BRF's own breeding-stock supplier and Argentina's largest chicken producer, pressed the government to keep the eggs out. 'They did everything to keep us from importing,' one source said. By mid-2018, with BRF in crisis, Parente's rescue plan put the Argentine assets up for sale in three parts — Avex, Quickfood and pork — with only Granja Tres Arroyos seen as a plausible buyer, at a very low price.

The acquisition thesis rested on exports that never materialised: Argentina lacked the accreditations, so the platform was a domestic operation with export-scale costs.

BRF never built the integrated supplier chain that makes its Brazilian chicken model work, and declined the $50 million fix in 2014–15 in favour of balance-sheet cosmetics.

Its own genetics supplier became its regulator's lobbyist, blocking the one supply fix that could have made the unit competitive.

An export platform without export accreditation is just a factory: buying capacity in a market whose licences and input chains you don't control buys losses, not scale.

The June 2018 divestment package — Argentina, Thailand and Europe, targeting R$5 billion by year-end to cut debt after the Carne Fraca scandal and its embargoes — put the Argentine operations up for sale via Bradesco BBI and Itaú BBA. Insiders expected the parts to sell separately, with Avex going cheap to its dominant local rival.